Disruption of the p16-cyclin D1-CDK4/6-RB pathway occurs frequently in many human cancers [2], and we investigated here the expression profiles of three distinct factors involved in this pathway: cyclin D1, CKD4 and p16. Here, RB1 is linked to cancer.